This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

Search ITCM

A Nobel Laureate and 2,000 International Research Scientists heading to Innsbruck

Congress Innsbruck
With the congress of the European Atherosclerosis Society set for the end of May, all the eyes of the medical world will be on Innsbruck. The key focus will be on the latest findings relating to the prevention of cardiovascular disease. The hotly anticipated keynote speaker is Nobel Laureate Michael S. Brown from the USA.

Many international studies have shown that atherosclerosis, commonly referred to as hardening of the arteries, together with its associated secondary diseases such as heart attacks, strokes, and pulmonary embolisms, is the most common cause of death in the Western world. More than 2,000 medical specialists and top scientists from all over the world will be flocking to Congress Innsbruck to discuss the latest findings and research results at the congress of the European Atherosclerosis Society (EAS) from May 29 to June 1.  

Major event with a forward-looking agenda
“Atherosclerosis and its associated diseases are a serious health problem worldwide. The EAS congress is an important major event that is held in a different European city each year. It aims to inspire and inform delegates with its forward-looking scientific agenda,” explains local EAS Congress President Professor Hans Dieplinger from the Medical University of Innsbruck.  

Keynote lecture from a Nobel Laureate
To give the keynote lecture, the congress is honored to be welcoming a distinguished Nobel Laureate from the USA, Professor Michael S. Brown, who was responsible for discovering the LDL receptor, a key factor in cholesterol metabolism. Professor Dieplinger says: “As president of the Austrian Atherosclerosis Society, which is hosting the congress, I am particularly delighted to be inviting renowned researchers and clinicians from all over the world to come to Innsbruck and take part in exciting lectures and workshops and to discuss the latest findings from atherosclerosis research.”  

New guidelines and prizes for young scientists
As well as addressing the many scientific topics of the day, the EAS is going to be issuing guidelines and consensus position papers, organizing advanced courses and online training, and awarding prizes to up-and-coming young scientists. “The EAS is also playing a pioneering role in collecting data on familial hypercholesterolemia and thus in preventing cardiovascular disease,” Dieplinger stresses.  

Symposium in the run-up to the congress
The 84th EAS congress will also be preceded by a lipoprotein(a) symposium, which is taking place two days before the main event and will attract some 200 delegates. “Together with cholesterol, raised levels of this lipoprotein in the blood are another atherogenic risk factor for cardiovascular disease. Austria has a long tradition of research in this field,” Dieplinger explains.  

“Great honor” for the CMI
Christian Mayerhofer, CEO of Congress Messe Innsbruck (CMI), is also particularly pleased to be welcoming this major congress to the city in the Alps: “We are delighted to be working hand in hand with this specialist European society, the local congress management team from the Medical University of Innsbruck, the international PCO Kenes, and everybody else involved in staging the EAS Conference 2016 in Innsbruck. It is a great honor for us to be part of this top international congress.”

Submit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TwitterSubmit to LinkedIn